A bibliometric analysis based on web of science: current perspectives and potential trends of SMAD7 in oncology
X Huang, Z Yang, J Zhang, R Wang, J Fan… - Frontiers in cell and …, 2022 - frontiersin.org
Background: The number of publications on SMAD7 in the field of oncology is increasing
rapidly with an upward tendency. In most cases, the mechanisms of carcinogenesis usually …
rapidly with an upward tendency. In most cases, the mechanisms of carcinogenesis usually …
The role of nutrition in primary and secondary prevention of cardiovascular damage in childhood cancer survivors
F Guida, R Masetti, L Andreozzi, D Zama, M Fabi… - Nutrients, 2022 - mdpi.com
Innovative therapeutic strategies in childhood cancer led to a significant reduction in cancer-
related mortality. Cancer survivors are a growing fragile population, at risk of long-term side …
related mortality. Cancer survivors are a growing fragile population, at risk of long-term side …
[HTML][HTML] L-carnitine protects cardiac damage by reducing oxidative stress and inflammatory response via inhibition of tumor necrosis factor-alpha and interleukin-1beta …
Brief introduction Myocardial infarction (MI) is a common manifestation of certain cardiac
diseases where oxidative stress and fibrosis aggravate the condition markedly. Main …
diseases where oxidative stress and fibrosis aggravate the condition markedly. Main …
Berberine hydrochloride alleviates imatinib mesylate–induced cardiotoxicity through the inhibition of Nrf2-dependent ferroptosis
C Song, D Li, J Zhang, X Zhao - Food & Function, 2023 - pubs.rsc.org
Imatinib mesylate (IMA) belonging to the selective tyrosine kinase inhibitor family has been
proven to induce cardiotoxic effects along with therapeutic strategies. Nrf2-dependent …
proven to induce cardiotoxic effects along with therapeutic strategies. Nrf2-dependent …
Role of ferroptosis in promoting cardiotoxicity induced by Imatinib Mesylate via down-regulating Nrf2 pathways in vitro and in vivo
C Song, D Li, J Zhang, X Zhao - Toxicology and applied pharmacology, 2022 - Elsevier
Imatinib Mesylate (IMA) has been widely used to treat with chronic myeloid leukemia (CML).
However, cardiotoxicity associated with IMA is included among the therapeutic strategies …
However, cardiotoxicity associated with IMA is included among the therapeutic strategies …
Depletion of lncRNA MEG3 ameliorates imatinib‐induced injury of cardiomyocytes via regulating miR‐129‐5p/HMGB1 axis
P Tang, J Zhou, H Liu, S Mei, K Wang… - Analytical Cellular …, 2023 - Wiley Online Library
Imatinib is a classical targeted drug to treat chronic myeloid leukemia (CML). However, it
shows cardiotoxicity, which limits its clinical application. Long noncoding RNA (lncRNA) …
shows cardiotoxicity, which limits its clinical application. Long noncoding RNA (lncRNA) …
Design, synthesis and anticancer evaluation of imamine-1, 3, 5-triazine derivatives
XY Xue, JL He, R Li, B Ding, WL Wu, YY Cao… - New Journal of …, 2024 - pubs.rsc.org
To find novel and effective anti-cancer agents, sixteen novel imamine-1, 3, 5-triazine
derivatives were firstly designed and synthesized using a molecular hybridization strategy …
derivatives were firstly designed and synthesized using a molecular hybridization strategy …
9.4 T static magnetic field ameliorates imatinib mesylate-induced toxicity and depression in mice
X Tian, C Wang, B Yu, Y Fan, L Zhang… - European Journal of …, 2023 - Springer
Purpose 9.4 T magnetic resonance imaging (MRI) has been initially tested on healthy
human volunteers, but its future application will benefit more from experiments with animal …
human volunteers, but its future application will benefit more from experiments with animal …
[HTML][HTML] Protective mechanisms of telmisartan against hepatic ischemia/reperfusion injury in rats may involve PPARγ-induced TLR4/NF-κB suppression
Hepatic ischemia-reperfusion (I/R) is an important cause of liver damage in many clinical
situations. Toll-like receptor 4 (TLR4)/nuclear factor-kappa B (NF-κB) is an inflammatory …
situations. Toll-like receptor 4 (TLR4)/nuclear factor-kappa B (NF-κB) is an inflammatory …
Zinc and L-carnitine combination with or without methotrexate prevents intestinal toxicity during arthritis treatment via Nrf2/Sirt1/Foxo3 pathways: an In vivo and …
R Katturajan, S Evan Prince - Inflammopharmacology, 2023 - Springer
Methotrexate (MTX) is an antifolate that is inescapable and widely used to treat autoimmune
diseases and is the gold standard medicine for the arthritic condition. Despite its importance …
diseases and is the gold standard medicine for the arthritic condition. Despite its importance …